Deletion of serine racemase reverses neuronal insulin signaling inhibition by amyloid‐β oligomers. Issue 1 (29th July 2022)
- Record Type:
- Journal Article
- Title:
- Deletion of serine racemase reverses neuronal insulin signaling inhibition by amyloid‐β oligomers. Issue 1 (29th July 2022)
- Main Title:
- Deletion of serine racemase reverses neuronal insulin signaling inhibition by amyloid‐β oligomers
- Authors:
- Zhou, Jing
Zhang, Zhiwen
yang, Yuanhong
liao, Fei
Zhou, Piansi
Wang, Yan
Zhang, He
Jiang, Haiyan
Alinejad, Tahereh
Shan, Ge
Wu, Shengzhou - Abstract:
- Abstract: Dysregulation of insulin signaling in the Alzheimer's disease (AD) brain has been extensively reported. Serine racemase (SR) modulates insulin secretion in pancreatic islets. This study aimed to examine whether SR regulates insulin synthesis and secretion in neurons, thereby modulating insulin signaling in the AD brain. Srr ‐knockout ( Srr −/− ) mice generated with the CRISPR/Cas9 technique were used. Using immunofluorescence and fluorescence in situ hybridization, levels of insulin protein and insulin ( ins2 ) mRNA were significantly increased in the hippocampal but not in hypothalamic sections of Srr −/− mice compared with WT mice. Real‐time quantitative PCR revealed that ins2 mRNA from primary hippocampal neuronal cultures of Srr −/− mice was significantly increased compared with that from cultured neurons of WT mice. Notably, the secretion of proinsulin C‐peptide was increased in Srr −/− neurons relative to WT neurons. By examining membrane fractional proteins with immunoblotting, Srr −/− neurons retained ATP‐dependent potassium channels on plasmalemma and correspondingly contained higher levels of p‐AMPK. After treatment with Aβ42, the phosphorylation levels of insulin receptor substrate at serine 616 636 (p‐IRS1 ser616, 636 ) were significantly lower, whereas p‐AKT 308 and p‐AKT 473 were higher in Srr −/− neurons than in WT neurons, respectively. The phosphorylated form of c‐Jun N‐terminal kinase decreased in the cultured Srr −/− neurons relative to the WTAbstract: Dysregulation of insulin signaling in the Alzheimer's disease (AD) brain has been extensively reported. Serine racemase (SR) modulates insulin secretion in pancreatic islets. This study aimed to examine whether SR regulates insulin synthesis and secretion in neurons, thereby modulating insulin signaling in the AD brain. Srr ‐knockout ( Srr −/− ) mice generated with the CRISPR/Cas9 technique were used. Using immunofluorescence and fluorescence in situ hybridization, levels of insulin protein and insulin ( ins2 ) mRNA were significantly increased in the hippocampal but not in hypothalamic sections of Srr −/− mice compared with WT mice. Real‐time quantitative PCR revealed that ins2 mRNA from primary hippocampal neuronal cultures of Srr −/− mice was significantly increased compared with that from cultured neurons of WT mice. Notably, the secretion of proinsulin C‐peptide was increased in Srr −/− neurons relative to WT neurons. By examining membrane fractional proteins with immunoblotting, Srr −/− neurons retained ATP‐dependent potassium channels on plasmalemma and correspondingly contained higher levels of p‐AMPK. After treatment with Aβ42, the phosphorylation levels of insulin receptor substrate at serine 616 636 (p‐IRS1 ser616, 636 ) were significantly lower, whereas p‐AKT 308 and p‐AKT 473 were higher in Srr −/− neurons than in WT neurons, respectively. The phosphorylated form of c‐Jun N‐terminal kinase decreased in the cultured Srr −/− neurons relative to the WT neurons upon Aβ42 treatment. In contrast, phosphorylated protein kinase R remained at the same levels. Further, reactive oxygen species were reduced in cultured Srr −/− neurons under Aβ42 treatment relative to the WT neurons. Collectively, our study indicated that Srr deletion promoted insulin synthesis and secretion of proinsulin C‐peptide, thereby reversing insulin resistance by Aβ42. This study suggests that targeting the neuronal SR may be utilized to enhance insulin signaling which is inhibited at the early stage of the AD brain. Abstract : Dysregulation of insulin signaling significantly contributes to neuronal demise and tau hyperphosphorylation in the AD brain. We demothat ablation of serine racemase (SR) increased insulin synthesis and the secretion of proinsulin C‐peptide in the neuron. The secretion of proinsulin C‐peptide was due to membrane translocation of the ATP‐dependent potassium (KATP ) channel. We further indicated that ablation of SR reversed neuronal insulin signaling inhibition induced by amyloid‐β oligomers. This reversal of insulin signaling was possibly due to the effects of the secreted C‐peptide. This study highlights a new strategy to enhance insulin signaling in the AD brain. Read the Editorial Highlight for this article on page 6 . … (more)
- Is Part Of:
- Journal of neurochemistry. Volume 163:Issue 1(2022)
- Journal:
- Journal of neurochemistry
- Issue:
- Volume 163:Issue 1(2022)
- Issue Display:
- Volume 163, Issue 1 (2022)
- Year:
- 2022
- Volume:
- 163
- Issue:
- 1
- Issue Sort Value:
- 2022-0163-0001-0000
- Page Start:
- 8
- Page End:
- 25
- Publication Date:
- 2022-07-29
- Subjects:
- Alzheimer's disease -- insulin -- insulin receptor substrate -- insulin resistance -- serine racemase
Neurochemistry -- Periodicals
616.8042 - Journal URLs:
- http://www.blackwell-synergy.com/loi/jnc ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/jnc.15664 ↗
- Languages:
- English
- ISSNs:
- 0022-3042
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5021.500000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 23932.xml